Mutational analysis of compound heterozygous mutation p.Q6X/p.H232R in SRD5A2 causing 46,XY disorder of sex development

• Published in: Italian journal of pediatrics Vol. 48; no. 1; pp. 47 - 13
• Main Authors: Li, Liwei, Zhang, Junhong, Li, Qing, Qiao, Li, Li, Pengcheng, Cui, Yi, Li, Shujun, Hao, Shirui, Wu, Tongqian, Liu, Lili, Yin, Jianmin, Hu, Pingsheng, Dou, Xiaowei, Li, Shuping, Yang, Hui
• Format: Journal Article
• Language: English
• Published: London BioMed Central 24.03.2022; BMC
• Subjects: 3-Oxo-5-alpha-Steroid 4-Dehydrogenase - genetics; 46,XY DSD; 5α-reductase 2 catalytic efficiency; Androgens; Clinical Genetics; Differences of sex development; Dihydrotestosterone; Dihydrotestosterone - metabolism; Efficiency; Enzymatic activity; Enzymes; Fetuses; Gene expression; HEK293 Cells; Heterozygote; Humans; Liquid chromatography; Mass spectroscopy; Maternal and Child Health; Medicine; Medicine & Public Health; Membrane Proteins - genetics; Molecular modelling; Mutation; Nonsense mutation; Ovaries; p.Q6X/p.H232R mutation; Pediatrics; Prostate; Proteins; Sexual Development; SRD5A2; Steroid 5α-reductase; Testosterone; Ultrasonic imaging; Uterus; 46,XY DSD; p.Q6X/p.H232R mutation; Dihydrotestosterone; 5α-reductase 2 catalytic efficiency; SRD5A2
• ISSN: 1824-7288; 1720-8424; 1824-7288
• DOI: 10.1186/s13052-022-01243-4

Background Over 100 mutations in the SRD5A2 gene have been identified in subjects with 46,XY disorder of sex development (DSD). Exploration of SRD5A2 mutations and elucidation of the molecular mechanisms behind their effects should reveal the functions of the domains of the 5α-reductase 2 enzyme and identify the cause of 46,XY DSD. Previously, we reported a novel compound heterozygous p.Q6X/p.H232R mutation of the SRD5A2 gene in a case with 46,XY DSD. Whether the compound heterozygous p.Q6X/p.H232R mutation in this gene causes 46,XY DSD requires further exploration. Methods The two 46,XY DSD cases were identified and sequenced. In order to identify the source of the compound heterozygous p.Q6X/p.H232R mutation, the parents, maternal grandparents, and maternal uncle were sequenced. Since p.Q6X mutation is a nonsense mutation, p.H232R mutation was transfected into HEK293 cells and dihydrotestosterone (DHT) production were analyzed by liquid chromatography–mass spectrometry (LC–MS) for 5α-reductase 2 enzyme activities test. Apparent michaelis constant (Km) were measured of p.H232R mutation to analyze the binding ability change of 5α-reductase 2 enzyme with testosterone (T) or NADPH. Results The sequence results showed that the two 46,XY DSD cases were the compound heterozygous p.Q6X/p.H232R mutation, of which the heterozygous p.Q6X mutation originating from maternal family and heterozygous p.H232R mutation originating from the paternal family. The function analysis confirmed that p.H232R variant decreased the DHT production by LC–MS test. The Km analysis demonstrated that p.H232R mutation affected the binding of SRD5A2 with T or NADPH. Conclusions Our findings confirmed that the compound heterozygous p.Q6X/p.H232R mutation in the SRD5A2 gene is the cause of 46,XY DSD. p.H232R mutation reduced DHT production while attenuating the catalytic efficiency of the 5α-reductase 2 enzyme.